Antimicrobial Activity of Bacillus amyloliquefaciens ANT1 Toward Pathogenic Bacteria and Mold: Effects on Biofilm Formation

Probiotics and Antimicrobial Proteins
Rosa Anna NastroPatrick Fickers

Abstract

The intensive use and misuse of antibiotics over the last decades have generated a strong selective pressure for the emergence of multi-resistant strains and nosocomial infections. Biofilm has been demonstrated as a key parameter in spreading infections, especially in hospitals and healthcare units. Therefore, the development of novel anti-biofilm drugs is actually of the upmost importance. Here, the antimicrobial and antibiofilm activities toward pathogenic microorganisms of a set of non-ribosomal synthesized peptides and polyketides isolated from Bacillus amyloliquefaciens ANT1 culture supernatant are presented.

References

Jun 28, 2001·The Journal of Antibiotics·T NagaoH Sano
Jul 27, 2002·Annual Review of Microbiology·P StoodleyJ W Costerton
Aug 16, 2002·Current Opinion in Biotechnology·Luanne Hall-Stoodley, Paul Stoodley
Dec 6, 2003·International Journal of Systematic and Evolutionary Microbiology·Daniel R Zeigler
Dec 3, 2005·International Journal of Antimicrobial Agents·T P Tim Cushnie, Andrew J Lamb
Sep 12, 2007·Journal of Natural Products·Kathrin SchneiderRoderich D Süssmuth
Feb 22, 2008·Trends in Microbiology·Marc Ongena, Philippe Jacques
Mar 28, 2008·Biotechnology and Bioengineering·James D Bryers
Jul 29, 2008·Research in Microbiology·Patrick FickersPhilippe Jacques
Apr 1, 1948·Proceedings of the Society for Experimental Biology and Medicine·M LANDY, G H WARREN
Oct 30, 2008·Journal of Molecular Microbiology and Biotechnology·Xiao-Hua ChenRainer Borriss
Jun 25, 2009·Chemical Society Reviews·Jordan L Meier, Michael D Burkart
Feb 16, 2010·Current Opinion in Structural Biology·Matthias StriekerMohamed A Marahiel
Jun 5, 2010·The Journal of Biological Chemistry·Lars Robbel, Mohamed A Marahiel
Apr 13, 2011·International Journal of Oral Science·Niels HøibyThomas Bjarnsholt
May 4, 2011·Journal of Food Science·Hua XuJuhee Ahn
May 21, 2011·FEMS Immunology and Medical Microbiology·Liang YangSøren Molin
Sep 13, 2011·American Journal of Infection Control·Victor D RosenthalUNKNOWN INICC members
Jun 27, 2012·Environmental Microbiology·Olaya RenduelesJean-Marc Ghigo
Sep 11, 2012·Advances in Applied Microbiology·Jamie L Brooks, Kimberly K Jefferson

❮ Previous
Next ❯

Citations

Dec 30, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chieu Anh Kim Ta, John Thor Arnason
Apr 30, 2020·The Biochemical Journal·Ruifang LiNanqi Pei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Revista de saúde pública
Laura S BerquóAndréa D Bertoldi
Ernst Schering Research Foundation Workshop
S DonadioL Cavaletti
The New Zealand Medical Journal
J Lexchin
BMQ; the Boston Medical Quarterly
L WEINSTEIN
© 2022 Meta ULC. All rights reserved